hVIVO (LON:HVO) Stock Price Down 6.8% – Time to Sell?

by · The Markets Daily

hVIVO plc (LON:HVOGet Free Report)’s share price fell 6.8% on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares changed hands during trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).

hVIVO Stock Performance

The company has a 50 day moving average price of GBX 23.20 and a 200-day moving average price of GBX 26.66. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The company has a market cap of £129.95 million, a P/E ratio of 636.67 and a beta of 0.97.

hVIVO Company Profile

(Get Free Report)

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.

Read More